相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Effects of Melatonin Supplementation on Parameters of Mental Health, Glycemic Control, Markers of Cardiometabolic Risk, and Oxidative Stress in Diabetic Hemodialysis Patients: A Randomized, Double-Blind, Placebo-Controlled Trial
Vahidreza Ostadmohammadi et al.
JOURNAL OF RENAL NUTRITION (2020)
Clinical impact of melatonin on breast cancer patients undergoing chemotherapy; effects on cognition, sleep and depressive symptoms: A randomized, double-blind, placebo-controlled trial
Ana Claudia Souza Palmer et al.
PLOS ONE (2020)
Melatonin supplementation and the effects on clinical and metabolic status in Parkinson's disease: A randomized, double-blind, placebo-controlled trial
Reza Daneshvar Kakhaki et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2020)
Association between night-shift work and level of melatonin: systematic review and meta-analysis
Tao Wei et al.
SLEEP MEDICINE (2020)
The effects of melatonin supplementation on mental health, metabolic and genetic profiles in patients under methadone maintenance treatment
Amir Ghaderi et al.
ADDICTION BIOLOGY (2019)
Exogenous melatonin as a treatment for secondary sleep disorders: A systematic review and meta-analysis
Tian Li et al.
FRONTIERS IN NEUROENDOCRINOLOGY (2019)
Adverse events associated with oral administration of melatonin: A critical systematic review of clinical evidence
Hope M. Foley et al.
COMPLEMENTARY THERAPIES IN MEDICINE (2019)
Sex differences in depression: Insights from clinical and preclinical studies
Rand S. Eid et al.
PROGRESS IN NEUROBIOLOGY (2019)
Effects of melatonin administration on mental health parameters, metabolic and genetic profiles in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial
Azade Shabani et al.
JOURNAL OF AFFECTIVE DISORDERS (2019)
The use of melatonin in adult psychiatric disorders: Expert recommendations by the French institute of medical research on sleep (SFRMS)
P. A. Geoffroy et al.
ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE (2019)
Selecting an Appropriate Animal Model of Depression
Yuanzhen Hao et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
The effect of melatonin on depressive symptoms and anxiety in patients after acute coronary syndrome: The MEDACIS randomized clinical trial
Michael Tvilling Madsen et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2019)
Depression in systemic lupus erythematosus: gender differences in the performance of the Beck Depression Inventory (BDI), Center for Epidemiologic Studies Depression Scale (CES-D), and Hospital Anxiety and Depression Scale (HADS)
E. A. Macedo et al.
LUPUS (2018)
Phytochemistry and pharmacology of anti-depressant medicinal plants: A review
Jeanette Martins et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Efficacy of melatonin for sleep disturbance following traumatic brain injury: a randomised controlled trial
Natalie A. Grima et al.
BMC MEDICINE (2018)
Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders: major depression summary
Gin S. Malhi et al.
MEDICAL JOURNAL OF AUSTRALIA (2018)
Pathophysiology of Depression: Molecular Regulation of Melatonin Homeostasis - Current Status
Monika Dmitrzak-Weglarz et al.
NEUROPSYCHOBIOLOGY (2018)
Antidepressant Medications An evidence-based review of the indications, adverse effects, and special considerations related to these medications.
Donna Sabella
AMERICAN JOURNAL OF NURSING (2018)
Circadian Rhythm and Melatonin in the Treatment of Depression
Senthil Kumaran Satyanarayanan et al.
CURRENT PHARMACEUTICAL DESIGN (2018)
The status of the Beck inventories (BDI, BAI) in psychology training and practice: A major shift in clinical acceptance
Chris Piotrowski
JOURNAL OF APPLIED BIOBEHAVIORAL RESEARCH (2018)
A randomized placebo-controlled trial evaluating the effect of melatonin on sleep quality in patients with mild-moderate dementia
Rocio Morales-Delgado et al.
EUROPEAN GERIATRIC MEDICINE (2018)
Comparing five depression measures in depressed Chinese patients using item response theory: an examination of item properties, measurement precision and score comparability
Yue Zhao et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2017)
Melatonin produces a rapid onset and prolonged efficacy in reducing depression-like behaviors in adult rats exposed to chronic unpredictable mild stress
Xiaoran Sun et al.
NEUROSCIENCE LETTERS (2017)
Melatonin as a treatment for mood disorders: a systematic review
F. De Crescenzo et al.
ACTA PSYCHIATRICA SCANDINAVICA (2017)
The Safety of Melatonin in Humans
Lars Peter Holst Andersen et al.
CLINICAL DRUG INVESTIGATION (2016)
Screening for Depression in the General Population with the Center for Epidemiologic Studies Depression (CES-D): A Systematic Review with Meta-Analysis
Gemma Vilagut et al.
PLOS ONE (2016)
Effect of melatonin on depressive symptoms and anxiety in patients undergoing breast cancer surgery: a randomized, double-blind, placebo-controlled trial
Melissa V. Hansen et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
A randomized, placebo-controlled trial of melatonin on breast cancer survivors: impact on sleep, mood, and hot flashes
Wendy Y. Chen et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
The therapeutic or prophylactic effect of exogenous melatonin against depression and depressive symptoms: A systematic review and meta-analysis
M. V. Hansen et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2014)
Role of melatonin in mood disorders and the antidepressant effects of agomelatine
Venkataramanujam Srinivasan et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2012)
Melatonin and its analogs in insomnia and depression
Daniel P. Cardinali et al.
JOURNAL OF PINEAL RESEARCH (2012)
Measures of Depression and Depressive Symptoms
Karen L. Smarr et al.
ARTHRITIS CARE & RESEARCH (2011)
A randomized double-blind placebo-controlled trial of treatment as usual plus exogenous slow-release melatonin (6 mg) or placebo for sleep disturbance and depressed mood
Marc Antony Serfaty et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2010)
A narrative review of the Beck Depression Inventory (BDI) and implications for its use in an alcohol-dependent population
A. McPherson et al.
JOURNAL OF PSYCHIATRIC AND MENTAL HEALTH NURSING (2010)
Comparison of two self-rating scales to detect depression: HADS and PHQ-9
Maja Hansson et al.
BRITISH JOURNAL OF GENERAL PRACTICE (2009)
Effect of bright light and melatonin on cognitive and noncognitive function in elderly residents of group care facilities - A randomized controlled trial
Rixt F. Riemersma-van der Lek et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Mechanisms of disease: Major depressive disorder
R. H. Belmaker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
The roles of melatonin and light in the pathophysiology and treatment of circadian rhythm sleep disorders
Seithikurippu R. Pandi-Perumal et al.
NATURE CLINICAL PRACTICE NEUROLOGY (2008)
Melatonin for perceived sleep disturbances associated with benzodiazepine withdrawal among patients in methadone maintenance treatment: a double-blind randomized clinical trial
Einat Peles et al.
ADDICTION (2007)
High-quality remission: potential benefits of the melatonergic approach for patients with major depressive disorder
Raymond W. Lam
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2007)
Agomelatine in the treatment of seasonal affective disorder
Edda Pjrek et al.
PSYCHOPHARMACOLOGY (2007)
Melatonin - Nature's most versatile biological signal?
S. R. Pandi-Perumal et al.
FEBS JOURNAL (2006)
Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia
Thomas Roth et al.
SLEEP MEDICINE (2006)
Sleep disturbances and depression: a challenge for antidepressants
RW Lam
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2006)
Melatonin in mood disorders
Venkataramanujan Srinivasan et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2006)
Melatonin improves bowel symptoms in female patients with irritable bowel syndrome: a double-blind placebo-controlled study
WZ Lu et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Melatonin improves abdominal pain in irritable bowel syndrome patients who have sleep disturbances: a randomised, double blind, placebo controlled study
GH Song et al.
GUT (2005)
Serum melatonin and urinary 6-sulfatoxymelatonin in major depression
M Crasson et al.
PSYCHONEUROENDOCRINOLOGY (2004)
Effect of controlled-release melatonin on sleep quality, mood, and quality of life in subjects with seasonal or weather-associated changes in mood and behaviour
S Leppämäki et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2003)
Assessing antidepressant activity in rodents: recent developments and future needs
JF Cryan et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2002)
The validity of the Hospital Anxiety and Depression Scale - An updated literature review
I Bjelland et al.
JOURNAL OF PSYCHOSOMATIC RESEARCH (2002)
The sensitivity and specificity of the Major Depression Inventory, using the Present State Examination as the index of diagnostic validity
P Bech et al.
JOURNAL OF AFFECTIVE DISORDERS (2001)
Effects of melatonin in perimenopausal and menopausal women: a randomized and placebo controlled study
G Bellipanni et al.
EXPERIMENTAL GERONTOLOGY (2001)
分享论文
